M I Marks, R M Shapera, M Brazeau. Show Affiliations »
Abstract
Mesh: See more » Anti-Bacterial Agents/administration & dosageAnti-Bacterial Agents/adverse effectsAnti-Bacterial Agents/therapeutic useBacterial Infections/drug therapyChildHumansPenicillin ResistancePenicillins/administration & dosagePenicillins/adverse effectsPolymyxins/administration & dosagePolymyxins/adverse effectsRifampin/administration & dosageRifampin/adverse effectsSpectinomycin/administration & dosageSpectinomycin/adverse effects
Substances: See more » Anti-Bacterial AgentsPenicillinsPolymyxinsSpectinomycinRifampin
Year: 1973 PMID: 4354180 PMCID: PMC1946864
Source DB: PubMed Journal: Can Med Assoc J ISSN: 0008-4409 Impact factor: 8.262